article thumbnail

Cognoa preps FDA filing for digital autism diagnostic

pharmaphorum

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. Cognoa has revealed however that the trial suggests the app is highly accurate across males and females as well as ethnic and racial backgrounds.

article thumbnail

5 Telehealth Providers to Rely on During Covid-19

Find Me Cure

However, other illnesses don’t just stop acting up because it’s not convenient for you to see your doctor. While it could be safe for some patients – especially if you call beforehand – to visit their doctor, many are either worried or their condition simply doesn’t leave room for any risks. Valley Health.

Doctors 69